Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT02619760
Eligibility Criteria:
Inclusion Criteria:
* Patients received percutaneous coronary intervention with cobalt-chromium everolimus-eluting stent
* Patients who are capable of oral dual antiplatelet therapy consisting of asprin and P2Y12 receptor antagonist
Exclusion Criteria:
* Patients requiring oral anticoagulants
* Patients with medical history of intracranial hemorrhage
* Patients who have experienced serious complications (myocardial infarction, stroke, and major bleeding) during hospital stay after percutaneous coronary intervention
* Patients with drug eluting stents other than Cobalt chromium everolimus eluting stents (Xience) implanted at the time of enrollment
* Patients comfirmed to have no tolerability to clopidgorel before enrollment
* Patients requiring continuous administration of antiplaelet drugs other than aspirin and P2Y12 receptor antagonists at the time of enrollment
* Patients with coronary bioabsorbable vascular scaffolds (BVS) implanted prior to or at the time of enrollment
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02619760
Study Brief:
Protocol Section:
NCT02619760